Insider Ownership: 24.2%

Earnings Growth Forecast: 61.5% p.a.

Mesoblast insiders have been actively buying shares, aligning with expectations of high revenue growth at 45.8% annually, surpassing the Australian market average. Despite a recent drop from the S&P/ASX Emerging Companies Index and reporting a net loss of US$87.96 million for the year ending June 2024, Mesoblast is trading significantly below its estimated fair value and is forecast to become profitable within three years, indicating potential for future growth.

• Dive into the specifics of Mesoblast here with our thorough growth forecast report.

• In light of our recent valuation report, it seems possible that Mesoblast is trading behind its estimated value.

Nanosonics

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Nanosonics Limited is an infection prevention company operating globally, with a market cap of A$982.91 million.

Operations: The company's revenue is derived entirely from its Healthcare Equipment segment, amounting to A$170.01 million.

Insider Ownership: 15.4%

Earnings Growth Forecast: 23.6% p.a.

Nanosonics has seen more insider buying than selling over the past three months, indicating confidence in its future prospects. The company's earnings are forecast to grow significantly at 23.6% annually, outpacing the Australian market average. However, revenue growth is slower at 8.7%. Despite trading 35.7% below estimated fair value, recent challenges include a drop from the S&P/ASX 200 Index and declining profit margins from last year’s figures.

• Get an in-depth perspective on Nanosonics' performance by reading our analyst estimates report here.

• Our valuation report here indicates Nanosonics may be overvalued.

Taking Advantage

• Access the full spectrum of 93 Fast Growing ASX Companies With High Insider Ownership by clicking on this link.

• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.

• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ASX:CMW ASX:MSB and ASX:NAN.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com